Biogen | BIIB - Ebit



金融业
股票价格
USD
资产
USD 29.48B
现金及等价物
USD 3.38B
销售成本
USD 797.5M
流动资产
USD 9.19B
流动负债
USD 3B
债务
USD 6.56B
EBIT
USD 514.3M
EBITDA
USD 649.7M
员工
7.61K
EPS每股收益
USD 3.57
股本和储备
USD 18.65B
销售毛利
USD 1.82B
债务利息支出
USD 72.6M
利息收入
USD 37.9M
贷款资金
USD 6.29B
市值
USD 28.88B
净收入
USD 319.5M
营业费用
USD 1.96B
营业利润
USD 514.3M
普通股股本
USD 146.7M
PE价格收益
13.7
税前利润
USD 377.7M
销售收入
USD 2.25B
销售和管理费用
USD 554.3M
股票
USD 1.95B
贸易债权人
USD 358.5M
应收帐款人
USD 1.79B


Ebit 更改 日
AbbVie USD 4.73B 1.08B 2026-03
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
ALKERMES USD -48.28M 37.33M 2026-03
Amgen USD 3.83B 130M 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Biogen USD 514.3M 502.8M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Gilead Sciences USD 2.68B 284M 2026-03
Incyte USD 344.17M 39.71M 2026-03
Merck USD -1.88B 8.12B 2026-03
Moderna USD -1.39B 531M 2026-03
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Novartis USD 4.18B 118M 2026-03
Pfizer USD 4.99B 340M 2026-03
PTC Therapeutics USD 45.89M 127.51M 2026-03
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Sanofi EUR 1.94B 239M 2026-03
Sanofi EUR 3.74B 2.23B 2025-09
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Teva Pharmaceutical Industries USD 758M 181M 2026-03
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
United Therapeutics USD 325.8M 340.4M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03